AstraZeneca PLC is 83.5x more valuable than NewAmsterdam Pharma Company N.V. by market capitalization ($286.27 B vs $3.43 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NAMS | AZN |
|---|---|---|
| Market cap | $3.43 B | $286.27 B |
| US-listed rank | #1703 | #45 |
| Revenue (latest FY) | $22.50M | - |
| Net income (latest FY) | -$203.00M | - |
| Net margin | -902.1% | - |
| SEC filings | 386 | 1,004 |
AstraZeneca PLC is 83.5x more valuable than NewAmsterdam Pharma Company N.V. by market capitalization ($286.27 B vs $3.43 B).
Full pages: NewAmsterdam Pharma Company N.V. and AstraZeneca PLC, or browse the full rankings.